Thymosin Beta-4 (tb4 recalls
The FDA has published 1 recall involving Thymosin Beta-4 (tb4 since 2025. The latest was reported on 15 Oct 2025. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2025
Last 12 months1reported
Class I00% of total
Ongoing1latest 15 Oct 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why thymosin beta-4 (tb4 is recalled
Companies
By year
Ongoing thymosin beta-4 (tb4 recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Thymosin Beta-4 (TB4) for Injection, 15mg recalled by GenoGenix | GenoGenix | Sterility | Nationwide |
All thymosin beta-4 (tb4 recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Thymosin Beta-4 (TB4) for Injection, 15mg recalled by GenoGenix | GenoGenix | Sterility | Nationwide |
Should you stop taking Thymosin Beta-4 (tb4?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.